Bank Of America Corp Avenue Therapeutics, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.22 - $0.96 $38 - $168	-176 Reduced 62.86%	104 $0
Q4 2021 Feb 08, 2022	BUY	$0.88 - $1.78 $6 - $12	7 Added 2.56%	280 $0
Q3 2021 Nov 15, 2021	SELL	$1.48 - $2.65 $2,103 - $3,765	-1,421 Reduced 83.88%	273 $0
Q2 2021 Sep 13, 2021	BUY	$2.41 - $7.11 $4,082 - $12,044	1,694 New	1,694 $4,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $10.1M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.